ETFs & Funds
Stopped out of $
at an average of $8. May look to re-establish trade later
I am long EXCEL since it was at $5 and also wrote puts on it. This will be a multi bagger.
Add a reply...
Latest StockTalks »
people get EXEL breaking news and analysis by email alert.
Get email alerts on EXEL »
Get latest price
From other sites
Exelixis' Cabozantinib Positive in Renal Cell Carcinoma Study
at Zacks.com (Feb 2, 2016)
Exelixis's Cabozantinib Granted Priority Review in the U.S.
at Zacks.com (Jan 29, 2016)
Roche-Exelixis' Cotellic-Zelboraf Combination Gets EC Nod
at Zacks.com (Nov 26, 2015)
Roche & Exelixis Announce Positive Data on Cotellic & Zelboraf
at Zacks.com (Nov 23, 2015)
The Zacks Analyst Blog Highlights: Gilead Sciences, Retrophin, Exelixis, Actelion and Enzo Biochem
at Zacks.com (Nov 11, 2015)